Rheum Round-up: IV vs. Oral TXA After Joint Surgery, AGA Crohn Recommendations, and more

Oral tranexamic acid (TXA) appears as effective as intravenous (IV) TXA in preventing blood loss in patients undergoing total knee and total hip replacement surgery, according to a study presented at the annual Regional Anesthesiology and Acute Pain Medicine Meeting, held from May 13 to 15 in Lake Buena Vista, Florida.

As part of a multimodal analgesic regimen in patients undergoing total knee arthroplasty, duloxetine cuts opioid use compared with placebo, according to a study presented at the annual Regional Anesthesiology and Acute Pain Medicine Meeting.

In clinical practice guidelines from the American Gastroenterological Association (AGA) published in the June 1 issue of Gastroenterology, recommendations are presented for the management of moderate-to-severe luminal and fistulizing Crohn disease in adult outpatients.

In Case You Missed It:

Oral, IV Tranexamic Acid Compared for Joint Replacement Surgery

Duloxetine Cuts Opioid Use After Total Knee Arthroplasty

AGA Issues Recommendations for Moderate-to-Severe Crohn Disease